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!"Abstract
Background: The in vitro diagnosis of pollen-related food allergy presents low specifi city and reproducibility with many conventional extracts. 
This can be improved using natural purifi ed allergens, recombinant purifi ed allergens, or both.
Objective: We compared specifi c immunoglobulin (Ig) E determination (sIgE), the basophil activation test (BAT), the histamine release test 
(HRT), and the cellular allergen stimulation test (CAST) using natural and recombinant allergens in the diagnosis of peach allergy. 
Methods: Thirty-two peach allergic patients were studied. Skin prick tests were performed with commercial peach and extract with Mal d 1, 
nPru p 3, and profi lin (nPho d 2). sIgE, BAT, CAST, and HRT were determined using rPru p 3, rMal d 3, rBet v 1, rMal d 1, and rMal d 4.
Results: Agreement between the techniques was good with all the allergens, except HRT with rMal d 1 and rMal d 4. With rPru p 3, 
sIgE, CAST, BAT, and HRT showed sensitivity values of 88%, 81%, 72%, and 69% and specifi city values of 100%, 93%, 97%, and 83%, 
respectively. In patients with systemic symptoms or contact urticaria, the values were 100%, 85%, 81%, and 81%. In patients with oral 
allergy syndrome, sensitivity to profi lins or homologues of Bet v 1 was detected in 100% of the cases by all the techniques, except by HRT 
with rMal d 1, which detected 66% of the cases. 
Conclusions: The use of single allergens in the in vitro diagnosis of peach allergy by specifi c IgE determination, BAT, and CAST offers high 
specifi city and sensitivity, with better results than the HRT.
Key words: Peach allergy. Component-resolved in vitro diagnosis. Basophil Activation Test. Histamine Release Test. Sulfi doleukotriene 
determination.
!"Resumen
Antecedentes: El diagnóstico de alergia alimentaria relacionada con pólenes es poco específi co y muestra una baja reproducibilidad entre 
los diferentes lotes de extractos convencionales utilizados para tal fi n. Este problema puede minimizarse utilizando alérgenos purifi cados 
naturales y/o recombinantes.
Objetivos: En este estudio comparamos la fi abilidad diagnóstica de dichos alérgenos purifi cados naturales y/o recombinantes en la 
determinación de IgE específi ca, test de activación de basófi los (TAB), test de  liberación de histamina (TLH), y en la producción antígeno 
específi ca de sulfi doleucotrienos (CAST), en el diagnóstico de alergia a melocotón.
Métodos: Se incluyeron en el estudio 32 pacientes alérgicos a melocotón a los que se realizaron pruebas cutáneas (prick test) con extracto 
comercial de melocotón y extracto enriquecido en Mal d 1, nPru p 3 y profi lina (nPho d 2). Se realizaron IgE específi ca, TAB, CAST y TLH 
utilizando rPru p 3, rMal d 3, rBet v 1, rMal d 1 y rMal d 4.
Resultados: En cuanto a los resultados obtenidos la concordancia entre las diferentes técnicas fue buena con todos los alérgenos, excepto 
para el test de liberación de histamina con Mal d 1 y Mal d 4. Utilizando  como alérgeno rPru p 3  la IgE específi ca, el CAST, TAB y TLH 
mostraron valores de sensibilidad de 88%, 81%, 72% y 69% con unas especifi cidades de  100%, 93%, 97% y 83% respectivamente.
En pacientes con síntomas sistémicos o con urticaria de contacto los valores de sensibilidad de dichas técnicas fueron de 100%, 85%, 
81% y 81%. En los pacientes con síndrome de alergia oral la sensibilidad  de las técnicas con profi lina o con homólogos de Bet v 1 fue 
del 100% para todas las técnicas, excepto para el TLH con Mal d1 que detecta el 66% de los casos.
Conclusiones: Mediante le determinación de IgE específi ca, TAB y CAST con alérgenos purifi cados obtenemos unos altos valores de 
sensibilidad y especifi cidad en el diagnóstico in vitro de alergia a melocotón, por encima de los observados mediante TLH.
Palabras clave: Alergia a melocotón. Diagnóstico basado en componentes. Test de activación de basófilos. Determinación de 
sulfi doleucotrienos.
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Introduction
In the diagnosis of allergy caused by fruits and vegetable 
food in general, skin tests with conventional total extracts present 
2 drawbacks: low specifi city [1,2] and low allergenic potency 
[3,4]. The use of fresh fruits in skin prick testing (SPT) is an 
alternative with low reproducibility problems due to variations 
in the allergenic content of the different species [5-9].
Of all the in vitro methods available today for the diagnosis 
of fruit allergy, specifi c immunoglobulin (Ig) E determination 
in whole extracts presents low specifi city due partly to the high 
content of glycoproteins with IgE-binding capacity, and to the 
presence of cross-reacting allergens. 
Natural or recombinant purifi ed food allergens have proven 
useful in the diagnosis of food allergy, by overcoming the 
limitations of commercial extracts and fresh foods [10,11].
Different authors have validated the reliability of these 
allergens for in vivo diagnosis by SPT [12-16]. In the present 
study, we compared the reliability of specifi c IgE determination 
(sIgE) and 3 cellular techniques–the basophil activation test 
(BAT), the cellular allergen stimulation test (CAST), and 
the histamine release test (HRT)–in the diagnosis of peach 
allergy. We used a wide panel of recombinant allergens that 
include the 3 families of allergens involved in peach allergy 
(Southern Europe, lipid transfer protein [LTP]; Central Europe; 
homologues of Bet v 1; and profi lins), rPru p 3, rMald 3, rBet 
v1, rMal d 1, and rMal d 4. We also compared them with peach 
commercial extracts.
Material and Methods
Patients and Challenge Tests
Thirty-two patients were studied (12 men, 20 women, age 
[SD] 26.8 [7 years]). They had all visited the allergy service of 
the Basurto Hospital in Bilbao, Spain, or the University Clinic 
of Navarre in Pamplona, Spain because of a potential peach 
allergy. All the patients presented symptoms compatible with 
peach allergy (oral allergy syndrome [OAS], contact urticaria, 
and/or systemic symptoms). A rubbing test with peach peel and 
skin tests with different allergens were performed on all patients 
[17]. Dermographism was ruled out in all the patients.
An open oral challenge test was performed on 26 patients 
starting with 1/8 of the peach weight for ethical reasons. It was 
not performed on patients with a recent history (< 1 year) of 
anaphylaxis after peach ingestion and with a positive SPT result 
and specifi c IgE result to peach for ethical reasons. Anaphylaxis 
was defi ned according the clinical criteria of Sampson [18]. 
The 6 patients who presented OAS underwent a double-
blind oral challenge test. The allergen was prepared and 
weighed, and administered at an amount equivalent to 1/8 of 
the peach weight; each dose was duplicated every 20 minutes 
until the equivalent of a whole peach was reached.
The patients were classifi ed into 3 groups according to their 
clinical history and oral challenge test result, as follows:
Group I: 6 peach-allergic patients with OAS only.
Group II: 20 peach-allergic patients with systemic 
symptoms (anaphylaxis, urticaria/angioedema).
Group III: 6 patients with peach-induced contact urticaria. 
The patients presented hives after contact with peach peel and 
all of them had a positive rubbing test result with peach peel. 
Within the group of OAS patients, 5 were allergic to grass 
pollen and 1 of them also to birch pollen.
Thirty control subjects were also selected (16 men and 14 
women): 10 were healthy subjects and 20 were pollen-allergic 
patients (mean age 30.6 years). Among the pollen allergic 
patients, 16 were monosensitized to grass pollen and 3 were 
sensitized to grass and birch pollen.
All control subjects underwent the same in vivo and in vitro 
determinations as the patients–an open oral challenge test and 
rubbing test–and the results of both assays were negative.
Prick Test
All the patients and controls underwent prick testing 
following the usual technique with the most frequent inhalant 
allergens in our environment and peach extracts (ALK-Abelló 
SA, Madrid, Spain). In addition, we performed SPT with natural 
purifi ed Pru p 3 (20 µg/mL), palm tree pollen profi lin (nPho 
d 2) (50 µg/mL), and Mal d 1-enriched golden apple extract 
[9]. Histamine hydrochloride (10 mg/mL) and physiological 
serum were used as positive and negative controls, respectively. 
The SPT result was considered positive when the mean wheal 
diameter was 3 mm or greater, compared with that produced 
by the negative control.
In vitro tests
Allergens. We used the following recombinant allergens: 
rPru p 3, rMal d3, rMal d 4, rBet v 1, and rMal d. These 
allergens were obtained, purified, and characterized as 
described elsewhere [19-21].
Specific IgE determination. Total and specific IgE 
determinations to apple, peach, Lolium perenne, Betula 
verrucosa, Artemisa vulgaris, rBet v 1, rBet v 2, and rPhl 
p 12 were determined by CAP (Phadia, Uppsala, Sweden) 
following the manufacturer’s instructions. In addition, specifi c 
IgE to rBet v 1, rMal d 1, rMal d 3, rMal d 4 and rPru p 3 was 
also determined using the ADVIA-Centaur platform (Bayer 
Diagnostics, Barcelona, Spain). 
BAT. BAT was performed as previously described 
[15,22,23]. Briefl y, blood was collected in 6-mL EDTA tubes 
and resuspended in 100-µg HEPES calcium buffer containing 
interleukin (IL) 3 (10 ng/mL). 
In the cellular stimulation phase, and simultaneously 
with CAST, 2 fi nal concentrations of the tested samples were 
assayed as follows: 2 and 0.5 mg/mL for peach peel, 2 and  0.3 
mg/mL for apple peel, and 0.3 and 0.1 µg/mL for the purifi ed 
recombinant allergens rPru p 3, rMal d 3, rBet v 1, rMal d 1, and 
rMal d 4. As a positive control, a monoclonal anti-IgE receptor 
antibody (Bühlmann Laboratories, Allschwil, Switzerland) at 
a concentration of 1 µg/mL was used.
In order to evaluate baseline values without stimulation, 
50 µL of stimulation buffer was added to another well 
and 50 µL of cell suspension was added to all wells. Soon 
afterwards, plates were centrifuged at 1000g for 5 min at 
4°C and 100 µL of supernatant was pipetted and saved for 
the sulphidoleukotriene (sLT) analysis by CAST–enzyme-
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Figure. Individual results of specifi c IgE determination (A), basophil activation test (B), histamine release (C), and antigen-specifi c sulfi doleukotriene 
production (D) to purifi ed and/or recombinant proteins in peach allergic patients with systemic reactions and OAS, and in pollen-allergic or healthy 
controls.
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Statistical Analysis
The data were analyzed with the statistical 
program SPSS 13.0 (SPSS Inc, Chicago, 
Illinois, USA). Qualitative variables were 
compared using the chi-square or Fisher exact 
test. A P value of less than .05 was considered 
statistically signifi cant.
The agreement between the 4 diagnostic 
techniques used was analyzed using the 
κ statistic. Variables were expressed 
dichotomously as positive-negative in order 
to simplify the interpretation of the results.
Results
The results of BAT and sIgE for rPru p 3, 
rMal d 3, rBet v 1, rMal d 1, rMal d 4, rBet 
v 2, and rPhl p 12 in 30 of these patients 
have already been published [29]. Given the 
similarity of the results obtained in groups II 
and III, and the lack of signifi cant differences 
in all the in vivo and in vitro parameters 
in these groups, we decided to merge both 
groups into one.
The results are summarized in the 
Figure and in Table 1.
Skin Tests
Of the 32 patients studied, 30 presented a 
positive response with the peach commercial 
extract and 29 with nPru p 3 (the 3 negative 
patients belonged to the OAS group). Five 
patients had a positive SPT result with Mal 
d 1–enriched golden apple extract. The OAS 
group showed positive results in 3 out of 
6 patients, and clear differences with the 
systemic symptoms group, where the SPT 
result was positive in 2 out of 26 patients. 
Six patients had positive SPT results with 
palm tree pollen profi lin (nPho d 2), 4 of 
them belonging to the OAS group and 2 to 
the systemic symptoms group.
In Vitro Tests
Commercial extract. The sensitivity of 
the 4 techniques studied ranged from 94% 
for specifi c IgE determination to 72% for 
HRT. Specifi city data was close to 100% in 
the healthy controls for all the techniques. 
Nevertheless, in the pollen-allergic controls, 
specifi city ranged from 50% in BAT to 90% 
in HRT.
LTP. Specifi c IgE to rPru p 3 showed the 
best sensitivity (28/32, 88%) and specifi city 
(100%) results of the 4 techniques. Sensitivity 
increased to 100% when only the patients 
with systemic symptoms were considered.
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In the other 3 techniques, the sensitivity in the global study 
group reached 70%-80%, which increased to 80%-85% in the 
systemic symptoms group. The specifi city of the 3 techniques, 
as well as CAP, was near 100% for both LTPs except in HRT 
with Pru p 3, which had a value of 83%. In the group of pollen-
allergic controls, the specifi city of specifi c IgE, BAT, and 
CAST with LTP was greater than that with peach commercial 
extract (P < .05).
Profi lin. HRT with Mal d 4 was only positive in 1 OAS 
patient. Nevertheless, sIgE (4 patients), BAT (5 patients), 
and CAST (6 patients) showed a totally different frequency 
of sensitization to profi lin compared with the patients with 
systemic symptoms (with a maximum of 23% detected by 
CAST with Mal d 4).
Sensitizations to profi lin in the control subjects were only 
detected with all 4 techniques in the pollinic group.
Bet  v 1 homologues. The 4 techniques detected sensitization 
to rBet v 1 in approximately 50% of the patients with OAS. 
Nevertheless, as with Mal d 4, HRT only detected 1 case of 
sensitization to rMal d 1 in that group, whereas the other 3 
techniques detected sensitization in 3-5 patients out of 6.
Specifi c IgE to rBet v 1 and rMal d 1 was positive in only 1 
of the 26 patients with systemic symptoms, whereas in the OAS 
group, 3 out of 6 were positive, and they all had positive SPT 
results with golden apple. Only one control patient, who was 
allergic to birch pollen, showed positive results to rMal d 1.
Sensitization to these allergens in the pollen-allergic 
control group was very low (5%), as determined by any of 
the 4 techniques.
Agreement Between In Vitro Allergy Tests
The results are summarized in Table 2. Agreement was good 
and shows statistical signifi cance between the 4 techniques used, 
particularly for LTP. Only 2 antigens, rMal d1 and rMal d 4, 
behaved differently, with no signifi cant agreement between 
HRT and the other in vitro tests. This is mainly due to the 
low sensitivity of HRT in the OAS group when using these 
allergens.
The agreements are particularly good between sIgE, SLT, 
and BAT for all the allergens tested.
Discussion
Our results show that the sensitivity of the 4 in vitro 
diagnostic techniques used is good, especially in the 
identifi cation of patients who are sensitized to Pru p 3, which 
is the main allergen of peach-allergic patients in southern 
Europe [30].
The specifi city of the 4 techniques using this allergen is 
also excellent, with values near 100% in sIgE, CAST, and 
BAT. Their specifi city is greater using rPru p 3 and rMal d 3 
than with the commercial peach extract, which shows low 
specifi city in the pollen-allergic control group for all the 
techniques used, except HRT. 
These results support the use of single allergens, and 
help us solve one of the main problems of the conventional 
extracts in daily clinical practice, that is, its low specifi city 
[1,2], particularly when these techniques are applied to 
pollen-allergic patients, who are the most diffi cult to diagnose 
properly [31-33]. 
It is worth noting that, in our study, agreement between 
skin prick testing and the different in vitro techniques carried 
out with rPru p 3 was good, as was agreement between the in 
vitro techniques. Therefore, the 4 in vitro techniques can be 
considered reliable when detecting sensitization to LTP in our 
peach-allergic patients. 
These values are comparable to those obtained in a 
multicenter European study carried out in cherry-allergic 
patients [12]. The authors showed that the agreement between 
SPT and sIgE was higher than 90% in patients sensitized to 
cherry LTP (rPru av 3).
In patients with OAS, sensitization to profilin, the 
predominant allergen in our environment [13,14], was 
identifi ed in 80%-100% of cases by all the techniques studied 
except HRT. Agreement between the 4 in vitro tests is similar 
to those obtained with LTPs and to those of Reuter et al [12], 
who established agreement of almost 100% between skin 
testing and sIgE with rPru av 4 in cherry-allergic patients. 
In short, and despite the small number of patients sensitized 
to profi lins in our series, which does not enable us to obtain 
conclusive results, it seems that, except for HRT, all the other 
techniques present similar diagnostic reliability.
Regarding the results obtained with rBet v 1 and rMal d 1, 
the usefulness of the 4 in vitro techniques to detect sensitization 
is similar to that of profi lins. In our study, HRT with rMal d 1 
did not show signifi cant agreement with the other techniques, 
and its sensitivity is particularly low in the group of patients 
with OAS. This result is not consistent with the fi ndings of 
Purohit et al [34] in Central Europe. These authors obtained 
positive results with HRT to rBet v 1 in all the patients studied 
with OAS caused by apple allergy, although with a low 
correlation between HRT and specifi c IgE determination. 
Osterballe et al [35] studied 10 patients with OAS by apple 
allergy, obtaining 70% sensitivity using HRT with Mal d 1. 
The small number of patients included in our study prevents 
us from comparing results. One possible explanation could 
be a lower degree of sensitivity among southern European 
patients, or a higher concentration of rBet v 1 needed to obtain 
a similar histamine release level in patients with OAS [35]. 
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with OAS caused by different foods [36].
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central European patients with OAS to apple. Purohit et al 
[34] found 100% sensitivity with sIgE to rBet v 1 in central 
European birch-allergic patients with OAS by Rosaceae. 
These results are similar to ours in the few patients sensitized 
to homologues of Bet v 1.
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